Clinical Trial Update: S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating radiotherapy with Carmustine, with or without O6-benzylguanine, in newly diagnosed glioblastoma multiforme or gliosarcoma has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Carmustine (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System | Phase 3 | Status: COMPLETED